Evidence map›Paper›PMID 28988156›Full record

ReviewCurrent opinion in microbiology2018

Antibiotic efficacy in the complex infection environment.

L Radlinski, B P Conlon

Abstract readReview
In one paragraph

Review in Current opinion in microbiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
5.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 83 citations in OpenAlex.

  1. The effect of selective decontamination on the intestinal microbiota as measured with IS-pro: a taxonomic classification tool applicable for direct evaluation of intestinal microbiota in clinical routine.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2022
    Trial
  2. Methicillin-resistantAntimicrobial agents and chemotherapy · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. mSphere · 2024
    Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Genotypic and phenotypic characterization ofbioRxiv : the preprint server for biology · 2024
    Article
  16. Review
  17. bioRxiv : the preprint server for biology · 2023
    Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

L RadlinskiDepartment of Microbiology and Immunology, University of North Carolina at Chapel Hill, NC, USA.
B P ConlonDepartment of Microbiology and Immunology, University of North Carolina at Chapel Hill, NC, USA; Marsico Lung Institute, University of North Carolina at Chapel Hill, NC, USA. Electronic address: bconlon@med.unc.edu.
Lung Institute · USUniversity of North Carolina at Chapel Hill · US

Funding

Investigating S. aureus persister formation under physiological conditionsK22AI125501 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI CONLON, BRIAN PATRICK · 2017 to 2018
$269k
NIAID NIH HHS K22 AI125501
6 · The paper itself

Abstract

Accurate prediction of antimicrobial efficacy is essential for successful treatment of bacterial infection. Beyond genetically encoded mechanisms of antibiotic resistance, the determinants of antibiotic susceptibility during infection remain poorly understood, and treatment failure is common. Traditional antibiotic susceptibility testing fails to account for extrinsic determinants of antibiotic susceptibility present in the complex infection environment and is therefore a poor predictor of antibiotic treatment outcome. Here we discuss how host-pathogen interaction, microbial interspecies interaction, and metabolic heterogeneity contribute to the success or failure of antibiotic therapy. Consideration of these factors during the treatment of disease will improve our ability to successfully resolve recalcitrant bacterial infection and improve patient health.

Indexed as

Anti-Bacterial AgentsBacterial InfectionsDrug Resistance, MicrobialHost-Pathogen InteractionsHumansMicrobial InteractionsMicrobial Sensitivity TestsTreatment OutcomeAnti-Bacterial Agents

Identifiers

PMID28988156
PMCPMC5889345
OpenAlexW2762033145

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.